AZD6738 Plus Durvalumab in Biliary Tract Cancer

NCT04298008 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Bile Duct Cancer
Chemotherapy Effect

Interventions

DRUG: AZD6738
DRUG: Durvalumab

Sponsor

Seoul National University Hospital